世界のリンパ腫治療薬販売市場2021

QYResearchが発行した調査報告書(QYR21JN7770)
◆英語タイトル:Global Lymphoma Drugs Sales Market Report 2021
◆商品コード:QYR21JN7770
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年4月22日(※2024年版があります。お問い合わせください。)
◆ページ数:133
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥888,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

QYリサーチ社の本調査レポートでは、世界のリンパ腫治療薬市場について種類別(経口、注射)、用途別(ホジキンリンパ腫、非ホジキンリンパ腫)、地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2016年~2027年までの市場規模と予測(販売量、売上、価格)、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・リンパ腫治療薬市場の概要
・世界の主要地域別リンパ腫治療薬市場規模2016-2027
・主要プレイヤーの競争状況・市場シェア
・世界のリンパ腫治療薬市場規模2016-2021:種類別(経口、注射)
・世界のリンパ腫治療薬市場予測2012-2027:種類別(経口、注射)
・世界のリンパ腫治療薬市場規模2016-2021:用途別(ホジキンリンパ腫、非ホジキンリンパ腫)
・世界のリンパ腫治療薬市場予測2012-2027:用途別(ホジキンリンパ腫、非ホジキンリンパ腫)
・リンパ腫治療薬のアメリカ市場規模と予測2016-2021
・リンパ腫治療薬のヨーロッパ市場規模と予測2016-2021
・リンパ腫治療薬の中国市場規模と予測2016-2021
・リンパ腫治療薬の日本市場規模と予測2016-2021
・リンパ腫治療薬の東南アジア市場規模と予測2016-2021
・リンパ腫治療薬のインド市場規模と予測2016-2021
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Roche、CHIPSCREEN、Johnson & Johnson、Abbvie、Celgene)
・リンパ腫治療薬の製造コスト分析
・販売チャネル、流通業者、顧客
・リンパ腫治療薬の市場動向・機会・課題
・調査の結論
【レポートの概要】

Lymphoma is cancer that begins in infection-fighting cells of the immune system, called lymphocytes. These cells are in the lymph nodes, spleen, thymus, bone marrow, and other parts of the body. When you have lymphoma, lymphocytes change and grow out of control.
The China average price of Lymphoma Drugs is in the decreasing trend, from 1560 USD/Unit in 2013 to 1373 USD/Unit In 2018. With the situation of China economy, prices will be in decreasing trend in the following five years.

Market Analysis and Insights: Global Lymphoma Drugs Market
The global Lymphoma Drugs market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Lymphoma Drugs Scope and Market Size
The global Lymphoma Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lymphoma Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Oral
Injection

Segment by Application
Hodgkin Lymphoma
Non-Hodgkin Lymphoma

The Lymphoma Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Lymphoma Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Roche
CHIPSCREEN
Johnson & Johnson
Abbvie
Celgene

【レポートの目次】

1 Lymphoma Drugs Market Overview
1.1 Lymphoma Drugs Product Scope
1.2 Lymphoma Drugs Segment by Type
1.2.1 Global Lymphoma Drugs Sales by Type (2016 & 2021 & 2027)
1.2.2 Oral
1.2.3 Injection
1.3 Lymphoma Drugs Segment by Application
1.3.1 Global Lymphoma Drugs Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hodgkin Lymphoma
1.3.3 Non-Hodgkin Lymphoma
1.4 Lymphoma Drugs Market Estimates and Forecasts (2016-2027)
1.4.1 Global Lymphoma Drugs Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Lymphoma Drugs Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Lymphoma Drugs Price Trends (2016-2027)

2 Lymphoma Drugs Estimates and Forecasts by Region
2.1 Global Lymphoma Drugs Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Lymphoma Drugs Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Lymphoma Drugs Sales Market Share by Region (2016-2021)
2.2.2 Global Lymphoma Drugs Revenue Market Share by Region (2016-2021)
2.3 Global Lymphoma Drugs Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Lymphoma Drugs Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Lymphoma Drugs Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Lymphoma Drugs Estimates and Projections (2016-2027)
2.4.2 Europe Lymphoma Drugs Estimates and Projections (2016-2027)
2.4.3 China Lymphoma Drugs Estimates and Projections (2016-2027)
2.4.4 Japan Lymphoma Drugs Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Lymphoma Drugs Estimates and Projections (2016-2027)
2.4.6 India Lymphoma Drugs Estimates and Projections (2016-2027)
3 Global Lymphoma Drugs Competition Landscape by Players
3.1 Global Top Lymphoma Drugs Players by Sales (2016-2021)
3.2 Global Top Lymphoma Drugs Players by Revenue (2016-2021)
3.3 Global Lymphoma Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Lymphoma Drugs as of 2020)
3.4 Global Lymphoma Drugs Average Price by Company (2016-2021)
3.5 Manufacturers Lymphoma Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Lymphoma Drugs Market Size by Type
4.1 Global Lymphoma Drugs Historic Market Review by Type (2016-2021)
4.1.1 Global Lymphoma Drugs Sales Market Share by Type (2016-2021)
4.1.2 Global Lymphoma Drugs Revenue Market Share by Type (2016-2021)
4.1.3 Global Lymphoma Drugs Price by Type (2016-2021)
4.2 Global Lymphoma Drugs Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Lymphoma Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Lymphoma Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Global Lymphoma Drugs Price Forecast by Type (2022-2027)
5 Global Lymphoma Drugs Market Size by Application
5.1 Global Lymphoma Drugs Historic Market Review by Application (2016-2021)
5.1.1 Global Lymphoma Drugs Sales Market Share by Application (2016-2021)
5.1.2 Global Lymphoma Drugs Revenue Market Share by Application (2016-2021)
5.1.3 Global Lymphoma Drugs Price by Application (2016-2021)
5.2 Global Lymphoma Drugs Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Lymphoma Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Lymphoma Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Lymphoma Drugs Price Forecast by Application (2022-2027)

6 North America Lymphoma Drugs Market Facts & Figures
6.1 North America Lymphoma Drugs Sales by Company
6.1.1 North America Lymphoma Drugs Sales by Company (2016-2021)
6.1.2 North America Lymphoma Drugs Revenue by Company (2016-2021)
6.2 North America Lymphoma Drugs Sales Breakdown by Type
6.2.1 North America Lymphoma Drugs Sales Breakdown by Type (2016-2021)
6.2.2 North America Lymphoma Drugs Sales Breakdown by Type (2022-2027)
6.3 North America Lymphoma Drugs Sales Breakdown by Application
6.3.1 North America Lymphoma Drugs Sales Breakdown by Application (2016-2021)
6.3.2 North America Lymphoma Drugs Sales Breakdown by Application (2022-2027)

7 Europe Lymphoma Drugs Market Facts & Figures
7.1 Europe Lymphoma Drugs Sales by Company
7.1.1 Europe Lymphoma Drugs Sales by Company (2016-2021)
7.1.2 Europe Lymphoma Drugs Revenue by Company (2016-2021)
7.2 Europe Lymphoma Drugs Sales Breakdown by Type
7.2.1 Europe Lymphoma Drugs Sales Breakdown by Type (2016-2021)
7.2.2 Europe Lymphoma Drugs Sales Breakdown by Type (2022-2027)
7.3 Europe Lymphoma Drugs Sales Breakdown by Application
7.3.1 Europe 133 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 133 Sales Breakdown by Application (2022-2027)

8 China Lymphoma Drugs Market Facts & Figures
8.1 China Lymphoma Drugs Sales by Company
8.1.1 China Lymphoma Drugs Sales by Company (2016-2021)
8.1.2 China Lymphoma Drugs Revenue by Company (2016-2021)
8.2 China Lymphoma Drugs Sales Breakdown by Type
8.2.1 China Lymphoma Drugs Sales Breakdown by Type (2016-2021)
8.2.2 China Lymphoma Drugs Sales Breakdown by Type (2022-2027)
8.3 China Lymphoma Drugs Sales Breakdown by Application
8.3.1 China 244 Sales Breakdown by Application (2016-2021)
8.3.2 China 244 Sales Breakdown by Application (2022-2027)

9 Japan Lymphoma Drugs Market Facts & Figures
9.1 Japan Lymphoma Drugs Sales by Company
9.1.1 Japan Lymphoma Drugs Sales by Company (2016-2021)
9.1.2 Japan Lymphoma Drugs Revenue by Company (2016-2021)
9.2 Japan Lymphoma Drugs Sales Breakdown by Type
9.2.1 Japan Lymphoma Drugs Sales Breakdown by Type (2016-2021)
9.2.2 Japan Lymphoma Drugs Sales Breakdown by Type (2022-2027)
9.3 Japan Lymphoma Drugs Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Lymphoma Drugs Market Facts & Figures
10.1 Southeast Asia Lymphoma Drugs Sales by Company
10.1.1 Southeast Asia Lymphoma Drugs Sales by Company (2016-2021)
10.1.2 Southeast Asia Lymphoma Drugs Revenue by Company (2016-2021)
10.2 Southeast Asia Lymphoma Drugs Sales Breakdown by Type
10.2.1 Southeast Asia Lymphoma Drugs Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Lymphoma Drugs Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Lymphoma Drugs Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Lymphoma Drugs Market Facts & Figures
11.1 India Lymphoma Drugs Sales by Company
11.1.1 India Lymphoma Drugs Sales by Company (2016-2021)
11.1.2 India Lymphoma Drugs Revenue by Company (2016-2021)
11.2 India Lymphoma Drugs Sales Breakdown by Type
11.2.1 India Lymphoma Drugs Sales Breakdown by Type (2016-2021)
11.2.2 India Lymphoma Drugs Sales Breakdown by Type (2022-2027)
11.3 India Lymphoma Drugs Sales Breakdown by Application
11.3.1 India Lymphoma Drugs Sales Breakdown by Application (2016-2021)
11.3.2 India Lymphoma Drugs Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Lymphoma Drugs Business
12.1 Roche
12.1.1 Roche Corporation Information
12.1.2 Roche Business Overview
12.1.3 Roche Lymphoma Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Roche Lymphoma Drugs Products Offered
12.1.5 Roche Recent Development
12.2 CHIPSCREEN
12.2.1 CHIPSCREEN Corporation Information
12.2.2 CHIPSCREEN Business Overview
12.2.3 CHIPSCREEN Lymphoma Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 CHIPSCREEN Lymphoma Drugs Products Offered
12.2.5 CHIPSCREEN Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Corporation Information
12.3.2 Johnson & Johnson Business Overview
12.3.3 Johnson & Johnson Lymphoma Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Johnson & Johnson Lymphoma Drugs Products Offered
12.3.5 Johnson & Johnson Recent Development
12.4 Abbvie
12.4.1 Abbvie Corporation Information
12.4.2 Abbvie Business Overview
12.4.3 Abbvie Lymphoma Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Abbvie Lymphoma Drugs Products Offered
12.4.5 Abbvie Recent Development
12.5 Celgene
12.5.1 Celgene Corporation Information
12.5.2 Celgene Business Overview
12.5.3 Celgene Lymphoma Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Celgene Lymphoma Drugs Products Offered
12.5.5 Celgene Recent Development

13 Lymphoma Drugs Manufacturing Cost Analysis
13.1 Lymphoma Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Lymphoma Drugs
13.4 Lymphoma Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Lymphoma Drugs Distributors List
14.3 Lymphoma Drugs Customers

15 Market Dynamics
15.1 Lymphoma Drugs Market Trends
15.2 Lymphoma Drugs Drivers
15.3 Lymphoma Drugs Market Challenges
15.4 Lymphoma Drugs Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のリンパ腫治療薬販売市場2021(Global Lymphoma Drugs Sales Market Report 2021)]についてメールでお問い合わせはこちらでお願いします。